The company launched in November 2024 with a specific mission: provide physician-formulated nutritional support for people using GLP-1 receptor agonist medications for weight management
Your medication is sourced from licensed 503A compounding pharmacies, ensuring pharmaceutical quality and safety, and is HSA/FSA eligible for additional savings
Retatrutide is a triple agonist (GIP + GLP-1 + glucagon)
It works by stimulating angiogenesis (the growth of new blood vessels), improving blood flow to injured areas and supporting the migration and proliferation of healing cells (Gwyer et al., 2019)
How They Compare Key Considerations Independent mechanisms: GHK-Cu and Tirzepatide work through different receptor systems, reducing interaction risk Complementary goals: GHK-Cu addresses skin anti-aging, wound remodeling, hair growth while Tirzepatide drives weight loss and metabolic improvement Physician supervision required: Any combination protocol should be designed and monitored by a licensed physician Sequential start: Begin one compound first, stabilize, then add the second to identify any individual reactions Frequently Asked Questions Is this combination safe
/assets/images/provider/photos/2798511.png)
